NYSE:KDMN

Kadmon - KDMN Stock Forecast, Price & News

$9.50

+0.02 (+0.21%)

(As of 11/8/2021)

Add

Compare

Today's Range: $9.48
▼
$9.50
50-Day Range: N/A
52-Week Range: $3.19
▼
$9.50

Volume: 10.42 million shs
Average Volume: 5.11 million shs
Market Capitalization: $1.70 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Kadmon (NYSE:KDMN) Stock

Kadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Its clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.

Receive KDMN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kadmon and its competitors with MarketBeat's FREE daily newsletter.

KDMN Stock News Headlines

September 24, 2022 | americanbankingnews.com

Kadmon (NYSE:KDMN) Earns Sell Rating from Analysts at StockNews.com

September 17, 2022 | americanbankingnews.com

Kadmon (NYSE:KDMN) Coverage Initiated by Analysts at StockNews.com

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive KDMN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kadmon and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceutical Preparation Manufacturing
Sub-Industry: N/A
Sector: Manufacturing
Current Symbol: NYSE:KDMN
CUSIP: N/A
CIK: N/A
Web: N/A
Phone: 12123086000
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 178,521,000
Free Float: N/A
Market Cap: $1.70 billion
Optionable: Optionable
Beta: N/A

Key Competitors

View All Competitors

KDMN Stock - Frequently Asked Questions

How have KDMN shares performed in 2022?: Kadmon's stock was trading at $9.50 at the beginning of the year. Since then, KDMN shares have increased by 0.0% and is now trading at $9.50.
View the best growth stocks for 2022 here.
What other stocks do shareholders of Kadmon own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Kadmon investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), OrganiGram (OGI), KushCo (KSHB), Gran Tierra Energy (GTE), Zosano Pharma (ZSAN), Bionano Genomics (BNGO), Pennsylvania Real Estate Investment Trust (PEI), Auxly Cannabis Group (CBWTF) and CNBX Pharmaceuticals (CNBX).
When did Kadmon IPO?: (KDMN) raised $101 million in an initial public offering on Wednesday, July 27th 2016. The company issued 5,600,000 shares at $16.00-$20.00 per share. Citigroup and Jefferies served as the underwriters for the IPO and JMP Securities and H.C. Wainwright & Co. were co-managers.

What is Kadmon's stock symbol?: Kadmon trades on the New York Stock Exchange (NYSE) under the ticker symbol "KDMN."
How do I buy shares of Kadmon?: Shares of KDMN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Kadmon's stock price today?: One share of KDMN stock can currently be purchased for approximately $9.50.
How much money does Kadmon make?: Kadmon (NYSE:KDMN) has a market capitalization of $1.70 billion.
How can I contact Kadmon?: Kadmon's mailing address is 450 E 29th St, New York, New York 10016-8367. The company can be reached via phone at 12123086000.

This page (NYSE:KDMN) was last updated on 9/26/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial Subscription Here

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms